Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.360
+0.010 (0.43%)
At close: Mar 28, 2025, 4:00 PM
2.340
-0.020 (-0.84%)
After-hours: Mar 28, 2025, 7:56 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $600.23 million as of March 28, 2025. Its market cap has decreased by -42.57% in one year.
Market Cap
600.23M
Enterprise Value
653.15M
1-Year Change
-42.57%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $600.23M, a decrease of -75.29%. That is a compound annual growth rate of -27.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 339.02M | -56.15% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | 2.75B | 13.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.49B |
| UnitedHealth Group | 473.94B |
| Johnson & Johnson | 395.05B |
| AbbVie | 361.62B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.88B |
| Merck & Co. | 225.84B |
| AstraZeneca | 225.00B |